The roundtable focused on anticompetitive PBM practices that drive up drug costs for American families, limit patient choice and squeeze community pharmacies.
Next week, on NACDS RxIMPACT Day on Capitol Hill, NACDS members and pharmacy advocates will push for PBM reform in-person to Congress and the Biden Administration.
Congress’ failure to enact PBM reforms for Americans in Medicare and Medicaid and for their pharmacies is nothing short of a wasted opportunity, pharmacy groups said.
The first panel at Drug Store News’ 25th annual Industry Issues Summit explored how retailers and pharmacy technology companies are changing the healthcare experience.